Impact of Blood Transfusions on Recurrence and Survival After Rectal Cancer Surgery |
| |
Authors: | Michael Jagoditsch MD Peter Pozgainer MD Anton Klingler PhD Joerg Tschmelitsch MD |
| |
Institution: | (1) Department of Surgery, Hospital of Barmherzige Brüder, St. Veit/Glan, Austria;(2) Theoretical Surgery Unit, Department of General and Transplant Surgery, Medical University Innsbruck, Innsbruck, Austria;(3) Department of Surgery, Hospital of Barmherzige Brüder, Spitalgasse 26, A-9300 St. Veit/Glan, Austria |
| |
Abstract: | Purpose This study was designed to determine whether type or number of blood units transfused affected short-term and long-term outcome
in patients undergoing surgery for rectal cancer. The number of perioperative blood units is associated with postoperative
mortality and overall survival by some authors. In addition, allogenic perioperative blood transfusion has been postulated
to produce host immunosuppression and has been reported to result in adverse outcome in patients with colorectal cancer. Autologous
blood transfusion might improve results compared with allogenic transfusion.
Methods Clinical outcome for 597 patients undergoing surgery for rectal cancer was analyzed according to their transfusion status.
Results for type (autologous or allogenic) and number of blood units transfused were recorded.
Results Blood transfusion was associated with increased postoperative mortality at 60 days. Patients who received > 3 units had a
postoperative mortality of 6 percent compared with 1 percent for patients who received 1 to 3 units and 0 percent for patients
who did not require transfusions. No difference was found between patients who received autologous or allogenic blood. Blood
transfusions were also associated with impaired overall survival in a univariate analysis, but this finding was not confirmed
in the multivariate analysis. The number or type of blood units transfused did not influence oncologic results. Local recurrence
rates, distant metastases rates, and disease-free survival were not influenced by transfusion in our patients.
Conclusions Increased numbers of blood units were associated with postoperative mortality. However, there is no reason, with respect to
cancer recurrence or disease-free survival, to use a program of transfusion with autologous blood in patients undergoing surgery
for rectal cancer.
Reprints are not available. |
| |
Keywords: | Rectal cancer Blood transfusion Recurrence Survival |
本文献已被 PubMed SpringerLink 等数据库收录! |
|